ADPT vs PTC · rev $142.4M vs P/E 48, rev $2.74B
Adaptive Biotechnologies Corp (ADPT) versus PTC Inc (PTC) — a side-by-side from cached financials, not a winner call.
Adaptive Biotechnologies Corp (ADPT) is a diagnostics & research company listed on NASDAQ.
PTC Inc (PTC) is a software - application company listed on US.
Latest reported ADPT revenue for 2026-06-30 was $142.4M. Net income was -$59.8M. ADPT currently screens at market cap $2.69B.
Latest reported PTC revenue for 2025-09-30 was $2.74B. Net income was $734.0M. PTC currently screens at market cap $21.11B and trailing P/E 48.3.
ADPT currently screens at market cap $2.69B. PTC currently screens at market cap $21.11B and trailing P/E 48.3.
Not investment advice. Open the ADPT and PTC stock pages for the full models.
Not investment advice.